European drugs authority EMA takes decision
Not directly against currently dominant subvariants but still...
By the European Medicines Agency
Final decision due in days
Was supposed to be ready by late March
Authorisation process in the USA is in preparation
Final review of Merck's pill to be made in February
54,000 doses this time
Works well with pneumonia shot too
At the start of the 'fifth wave' vaccine shortage is not a problem, reluctance is
Awarded by the American Academy Achievement
Prime Minister holds press briefing
Coronavirus Press Centre confirms Portfolio scoop
New milestone in the vaccination programme
Finding could accelerate administration of booster doses worldwide
No indication that vaccine is less able to prevent severe illness or death
Nearly 11 million doses delivered
Total up to nearly 10 million
High efficacy, favourable safety profile in Phase 3 trial
At the Food and Drug Administration
